P

Inventor

SHEPARD STACEY

US59 patents
⚠️ This page may combine multiple inventors who share the name “SHEPARD STACEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

38 patents
US9079912B2Jul 14, 2015

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitors

INCYTE CORP75 citations99
US7598257B2Oct 6, 2009

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

INCYTE CORP328 citations99
US10639310B2May 5, 2020

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

INCYTE CORP20 citations98
US10398699B2Sep 3, 2019

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

INCYTE CORP31 citations98
US9974790B2May 22, 2018

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

INCYTE CORP40 citations98
US9662335B2May 30, 2017

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

INCYTE CORP25 citations98
US9206187B2Dec 8, 2015

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase

INCYTE CORP55 citations98
US8933086B2Jan 13, 2015

Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors

INCYTE CORP71 citations98
US9334274B2May 10, 2016

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

INCYTE CORP57 citations97
US7834022B2Nov 16, 2010

Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP141 citations95
US11331320B2May 17, 2022

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

INCYTE CORP12 citations94
US10640506B2May 5, 2020

Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors

INCYTE CORP19 citations94
US10442803B2Oct 15, 2019

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP17 citations94
US10138248B2Nov 27, 2018

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

INCYTE CORP36 citations94
US9777003B2Oct 3, 2017

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP25 citations94
US9309246B2Apr 12, 2016

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP33 citations94
US9193733B2Nov 24, 2015

Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

INCYTE CORP33 citations94
US9814722B2Nov 14, 2017

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

INCYTE CORP13 citations93
US10065963B2Sep 4, 2018

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP16 citations92
US11091484B2Aug 17, 2021

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP8 citations84
US10975088B2Apr 13, 2021

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

INCYTE CORP6 citations84
US10738057B2Aug 11, 2020

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP5 citations84
US10479795B2Nov 19, 2019

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

INCYTE CORP13 citations84
US10472368B2Nov 12, 2019

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP12 citations84
US10463667B2Nov 5, 2019

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP5 citations83
US9512161B2Dec 6, 2016

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP9 citations82
US11926630B2Mar 12, 2024

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP2 citations73
US11926616B2Mar 12, 2024

Aminopyrazine diol compounds as PI3K-γ inhibitors

INCYTE CORP2 citations73
US11744832B2Sep 5, 2023

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

INCYTE CORP0 citations73
US11352340B2Jun 7, 2022

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

INCYTE CORP3 citations73
US11225486B2Jan 18, 2022

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP4 citations73
US11091491B2Aug 17, 2021

Heterocyclic compounds as PI3K-y inhibitors

INCYTE CORP4 citations73
US10669262B2Jun 2, 2020

Aminopyrazine diol compounds as PI3K-γ inhibitors

INCYTE CORP4 citations73
US11161838B2Nov 2, 2021

Heterocyclic derivatives as PI3K inhibitors

INCYTE CORP4 citations72
US11078204B2Aug 3, 2021

Heterocyclic derivatives as PI3K inhibitors

INCYTE CORP2 citations72
US11046658B2Jun 29, 2021

Aminopyrazine derivatives as PI3K-γ inhibitors

INCYTE CORP4 citations72
US11691971B2Jul 4, 2023

Naphthyridinone compounds as JAK2 V617F inhibitors

INCYTE CORP1 citations63
US11396502B2Jul 26, 2022

Substituted heterocyclic derivatives as PI3K inhibitors

INCYTE CORP1 citations63

RODGERS JAMES D

12 patents
US8530485B2Sep 10, 2013

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D98 citations99
US8158616B2Apr 17, 2012

Azetidine and cyclobutane derivatives as JAK inhibitors

RODGERS JAMES D170 citations99
US8946245B2Feb 3, 2015

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D70 citations98
US8933085B2Jan 13, 2015

Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

RODGERS JAMES D96 citations98
US8541425B2Sep 24, 2013

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D92 citations98
US8420629B2Apr 16, 2013

Azetidine and cyclobutane derivatives as JAK inhibitors

RODGERS JAMES D105 citations98
US8415362B2Apr 9, 2013

Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D117 citations98
US8889697B2Nov 18, 2014

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D79 citations97
US8716303B2May 6, 2014

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

RODGERS JAMES D109 citations97
US8486902B2Jul 16, 2013

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D125 citations97
US8748401B2Jun 10, 2014

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D80 citations96
US9249145B2Feb 2, 2016

Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

RODGERS JAMES D45 citations94

Showing the top 50 of 59 patents by PatentIndex Score.